By Sriparna Roy (Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of ...

Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...

The number of people living with a history of cancer in the United States is estimated at 18.6 million as of January 1, 2025 ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

It started with a dull ache in my right shoulder. At first, I chalked it up to bad posture or sleeping funny. Then came a ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment ...

The Bank of Korea (BOK) will lower its key policy rate by 25 basis points on Thursday as economic activity contracted in the last quarter and benign inflation supports the case for easing, a Reuters ...

"Lung cancer has not traditionally been thought of ... His takeaway is one you've likely heard across a dinner table. "Prioritizing a nutrient-rich diet, maintaining an active lifestyle and ...

Early-stage lung cancer was detected as a nodule during a routine check ... “You’re getting warm soon.” Lying on the operating table, I tried to face up to see Da Vinci, but she had already set the ...